Dendritic cell vaccines in glioma treatment
10.3760/cma.j.issn.1673-422X.2011.08.012
- VernacularTitle:树突状细胞疫苗治疗脑胶质瘤进展
- Author:
Hao XU
;
Zhanxiang WANG
- Publication Type:Journal Article
- Keywords:
Dendritic cells;
Glioma;
Cancer vaccines;
Immunotherapy
- From:
Journal of International Oncology
2011;38(8):596-598
- CountryChina
- Language:Chinese
-
Abstract:
Dendritic cell ( DC)-based tumor vaccine is applied to the gliomas treatment. Target selection heightens the specificity of DC vaccine, while obtaining of highly immunogenic long-lived and more effective DC vaccines by genetic engineering to antiapoptotic protein gene transfer. With the accumulation of clinical experience, the clinical curative effect of DC vaccine has been materially improved.
